SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-19-018841
Filing Date
2019-12-06
Accepted
2019-12-06 16:10:21
Documents
1
Effectiveness Date
2019-12-06

Document Format Files

Seq Description Document Type Size
1 form8-k.htm DEFA14A 23820
  Complete submission text file 0001493152-19-018841.txt   25133
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-13789 | Film No.: 191273218
SIC: 2834 Pharmaceutical Preparations